Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu, Philippe Clevenbergh, Roger Echols, Keith S. Kaye, Marin H. Kollef, Anju Menon, Jason M. Pogue, Andrew F. Shorr, Jean‐François Timsit, Markus Zeitlinger, Tsutae Den Nagata